India: Diabetes market to hit $806m in 2019 says new report

April 13, 2011 - PRLog -- According to the report ‘Commercial Insight: Antidiabetics in India’ now available at: http://www.pharmaceutical-market-research.com/go/DAT26520 fueled by the anticipated launch of new therapies, the Indian diabetes market, sized at $440m in 2009, will double in size by 2019. The market will see a significant shift in brand use: despite a slow start incretin mimetic therapies will come to play an important role in the non-insulin market segment.

The antidiabetic market in India is expected to grow from $441m in 2009 to $806m in 2019, demonstrating a compound annual growth rate (CAGR) of 6.2%. Although strongest growth is expected in the non-insulin market, with a 2009–19 CAGR of 7% and sales of $626m in 2019, the insulin market will generate revenues of $179m in 2019

Growth in the Indian diabetes market will be tempered by insulin analog biosimilars and the early launch of generics for patent-protected novel antidiabetics

DPP-IV inhibitors Januvia, vildagliptin, Onglyza and later class entrants, boast considerable advantages in terms of safety and tolerability, while the GLP-1 agonist class has good efficacy. However, due to a lack of reimbursement options and the high price of these incretin mimetic drugs, uptake will be limited by patient affordability

Product ID: DAT26520

About: http://www.pharmaceutical-market-research.com/publication... is the source for information products concerning the global biotechnology, healthcare, medical device and pharmaceutical industries. With over 20,000 market reports available, executives can find a current and comprehensive range of specialised intelligence. www.pharmaceutical-market-research.com is a service from Piribo Ltd, which was founded in 2004.

# # #

About Piribo.
Piribo http:www.piribo.com is the source for information products concerning the global biotechnology and pharmaceutical industries. Here you can browse and buy thousands of business information studies, market reports and books.